Impact of the infectious disease team on the rationale for antibiotic usage: An expeditious intervention strategy which avoids limiting the physician's freedom

Journal of Chemotherapy

Volumn 15, Issue 4, 2003, Pages 409-411

  Jasovich, Abel ^a,b   Curcio, D ^a   Caso Nunez H ^a   Fernandez, F ^a   Jetuchowitz, V ^a   Prieto, S ^a   Belloni, C ^a  

^a Quilmes Trinity Cardiovasc Center   (Argentina)

^b Hospital Zonal General de Agudos Dr Carlos Bocalandro   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARGENTINA; ARTICLE; BACTERIAL INFECTION; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; INFECTION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PHYSICIAN; PRESCRIPTION;

EID: 0042347812     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.4.409     Document Type: Article

References (3)

1. Crowe HM, Quintiliani R. Antibiotic Formulary Selection. In: Cunha B, Guest Editor. The Medical Clinics of North America, Antimicrobial Therapy I, W.B. Saunders Company May 1995:79(3);463-76.
2. Nathwani D. How do you measure the impact of an antibiotic policy? J Hosp Infect 1999; 43 Suppl: S265-8.
3. Kassirer JP. Doctor discontent. N Engl J Med 1998; 339(21): 1543-44.